Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.9K Buy
+13,375
New +$7.99K ﹤0.01% 2941
2024
Q2
Sell
-23,718
Closed -$95.8K 2665
2024
Q1
$95.8K Buy
+23,718
New +$89.5K ﹤0.01% 2495
2023
Q4
Sell
-13,227
Closed -$70.5K 2559
2023
Q3
$70.5K Sell
13,227
-67,788
-84% -$550K ﹤0.01% 2145
2023
Q2
$759K Buy
+81,015
New +$711K ﹤0.01% 1726
2022
Q2
Sell
-40,744
Closed -$377K 2836
2022
Q1
$377K Buy
40,744
+30,735
+307% +$231K ﹤0.01% 1873
2021
Q4
$94K Buy
+10,009
New +$92.9K ﹤0.01% 1970

Other funds holding DCGO

Dmitry Balyasny's DCGO Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in DocGo (DCGO) in Q2 2026: 13,375 shares worth $6.9K. The stake represents ﹤0.01% of the portfolio and ranks #2941 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in DCGO as recently as Q1 2024.

Dmitry Balyasny first reported a position in DCGO in Q4 2021 and has held it in 6 quarters since. The position peaked at $759K in Q2 2023. 118 funds tracked by Wall St. Rank hold DCGO as of Q2 2026.

  • Dmitry Balyasny held 13,375 shares of DocGo worth $6.9K as of Q2 2026.
  • DocGo was a new Dmitry Balyasny position in Q2 2026.
  • DocGo made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2941 holding.
  • Dmitry Balyasny first reported a position in DocGo in Q4 2021 and has held it in 6 quarters since.
  • Dmitry Balyasny's DocGo position peaked at $759K in Q2 2023.
  • 118 funds tracked by Wall St. Rank held DocGo as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.